Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3D66

Crystal structure of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI)

Experimental procedure
Experimental methodSINGLE WAVELENGTH
Source typeSYNCHROTRON
Source detailsESRF BEAMLINE ID29
Synchrotron siteESRF
BeamlineID29
Temperature [K]100
Detector technologyCCD
Collection date2007-03-10
DetectorADSC QUANTUM 315
Wavelength(s)1.26206
Spacegroup nameP 31 2 1
Unit cell lengths161.740, 161.740, 139.450
Unit cell angles90.00, 90.00, 120.00
Refinement procedure
Resolution49.510 - 3.100
R-factor0.20621
Rwork0.204
R-free0.24038
Structure solution methodMOLECULAR REPLACEMENT
Starting model (for MR)1kwm
RMSD bond length0.018
RMSD bond angle1.751
Data reduction softwareXDS
Data scaling softwareXDS
Phasing softwarePHASER
Refinement softwareREFMAC (5.2.0019)
Data quality characteristics
 OverallOuter shell
Low resolution limit [Å]49.5103.270
High resolution limit [Å]3.1003.100
Rmerge0.1050.833
Number of reflections38593
<I/σ(I)>13.92.6
Completeness [%]100.0100
Redundancy8.68.7
Crystallization Conditions
crystal IDmethodpHtemperaturedetails
1VAPOR DIFFUSION627716-18% PEG 3000, 0.18-0.22mM Na/K-tartrate, 50mM L-glutamate, 50 mM L-arginine, pH 6.0, VAPOR DIFFUSION, temperature 277K

229380

PDB entries from 2024-12-25

PDB statisticsPDBj update infoContact PDBjnumon